What does the evidence suggest about cardiovascular risk with abacavir?

Although clinical and observational findings are inconsistent, several studies suggest increased cardiovascular risk, notably myocardial infarction, with abacavir; modifiable risk factors should be minimised, and alternative regimens considered for patients at high cardiovascular risk.